Globally recognised Alzheimer's researcher Professor Ralph Martins AO has been appointed the inaugural Chair of Alzheimer's Research at The University of Western Australia through a $6 million partnership between UWA, Alzheimer's Research Australia and Lion's Alzheimer's Foundation.
The endowed chair aims to improve the lives of those affected by Alzheimer's disease – the most common form of dementia and the leading cause of death in Australia – by driving transformational change in research to advance prevention, treatment and care.
Professor Martins' insight into this devastating disease has significantly advanced the understanding of Alzheimer's globally.
Along with his team, Professor Martins has been at the forefront in developing non-invasive and cost-effective early diagnostics for pre-clinical Alzheimer's disease.
Professor Martins' research has identified Alzheimer's-related blood-based proteins, a breakthrough with the potential for a low-cost blood test for early detection.
UWA Deputy Vice-Chancellor (Research) Professor Anna Nowak said the University was thrilled to appoint Professor Martins as the inaugural Chair.
"Professor Martins is internationally recognised as a pioneer in Alzheimer's disease research, with a distinguished career spanning more than four decades," Professor Nowak said.
"His groundbreaking work has significantly advanced our understanding of the causes, early detection, and potential treatments for Alzheimer's disease.
"His appointment marks a significant step forward in the University's commitment to addressing one of the most serious health challenges and his vision aligns with UWA's mission to drive innovation, excellence, and community impact in medical research.
"Through his leadership, UWA will strengthen its position at the forefront of dementia research, education and clinical practice.
"Professor Martins will play a pivotal role in mentoring the next generation of researchers, expanding collaborative networks, and advancing strategies for prevention, early detection and treatment of Alzheimer's disease."
